The treatment of patients having spontaneously occurring antibodies to antihaemophilic factor (factor VIII).
D001323:Autoantibodies; D001379:Azathioprine / Q000627:therapeutic use; D001778:Blood Coagulation Disorders / Q000175:diagnosis / Q000188:drug therapy / Q000628:therapy*; D001780:Blood Coagulation Tests; D003450:Cryoglobulins / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D005169:Factor VIII / Q000037:antagonists & inhibitors* / Q000627:therapeutic use; D005260:Female; D006470:Hemorrhage / Q000188:drug therapy; D006801:Humans; D007074:Immunoglobulin G; D008297:Male; D008875:Middle Aged; D011239:Prednisolone / Q000627:therapeutic use; D011517:Prothrombin Time
D001323:Autoantibodies; D003450:Cryoglobulins; D007074:Immunoglobulin G; D003520:Cyclophosphamide; D005169:Factor VIII; D011239:Prednisolone; D001379:Azathioprine